Stay updated on Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.

Latest updates to the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has updated its version from v2.15.0 to v2.15.2 and removed several past dates, indicating a refresh in content and possibly functionality.SummaryDifference0.9%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated to include new information about a clinical trial for Plasma Cell Myeloma, specifically detailing the study's location and collaborators, while removing extensive descriptions of the treatment regimen and objectives associated with ixazomib, lenalidomide, dexamethasone, and daratumumab.SummaryDifference44%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.